Evaluation of Dynamic Balance After Recovery From COVID 19 Disease
1 other identifier
observational
25
1 country
1
Brief Summary
effect of post covid-19 on dynamic balance in patients after recovery from covid-19 disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2023
CompletedFirst Submitted
Initial submission to the registry
April 11, 2023
CompletedFirst Posted
Study publicly available on registry
April 14, 2023
CompletedApril 19, 2023
April 1, 2023
10 months
April 11, 2023
April 15, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
overall (OA), the anteroposterior (AP) and the Medio lateral (ML) stability scores
A high score in the OA index indicates poor balance. The OA stability score is believed to be the best indicator of the overall ability of the patient to balance the platform
2 to24 WEEKS after their recovery from the disease
Interventions
The balance tests of the patients were performed 2 to24 WEEKS after their recovery from the disease, which was confirmed by the evaluations of the Covid-19 staff and negative polymerase chain reaction test.
Eligibility Criteria
25 patients (males and females) who recovered from Covid-19 disease will be selected from 6 october unversity Hospital outpatient Clinic their age from 30 -40 years old and 25 healthyage and gender matched (males and females
You may qualify if:
- post COVID-19 patients suffering from inbalance.
- Age will be ranged from 30 to 40 years old.
- Body mass index (BMI) will be ranged from 25 to 35 Kg/m2.
- Diagnosed as COVID-19 patients with a positive reverse transcription polymerase chain reaction (RT-PCR) result of SARS-CoV-2, or typical computerized tomography (CT) evidence of viral pneumonia.
- All enrolled patients with moderate covid-19 infection.
You may not qualify if:
- Severe disease or hospitalization at intensive care units will excluded from the study.
- Patients with previous hearing problems or balance disorders.
- Patients who had ear surgery, cardiovascular and circulatory problems,.
- Patients with orthopedic problems in the lower extremities due to other problems
- Patients with Any history of neurological or psychiatric disease, severe visual or auditory impairments.
- Diabetic patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
October 6 u
El-Sheikh Zayed City, Giza Governorate, 1133, Egypt
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
April 11, 2023
First Posted
April 14, 2023
Study Start
February 20, 2022
Primary Completion
December 30, 2022
Study Completion
March 21, 2023
Last Updated
April 19, 2023
Record last verified: 2023-04